Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TATVA vs LIN, SHW, ECL: Days Payable Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Days Payable distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Days Payable falls into.
Tatva Chintan Pharma Chem Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Tatva Chintan Pharma Chem's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (NSE:TATVA) has a Days Payable of 70.59 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tatva Chintan Pharma Chem and its competitors. This is near median its historical median of 72.61. Over the past decade, Tatva Chintan Pharma Chem's Days Payable has ranged from 59.67 to 91.15. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #716 out of 1554 companies in the Chemicals industry, placing it in the top 46.1%.
Is Tatva Chintan Pharma Chem's Days Payable too high?
Tatva Chintan Pharma Chem's current Days Payable of 70.59 is near median its 10-year median of 72.61. Over the past 10 years, this metric has ranged from a low of 59.67 to a high of 91.15. The Chemicals industry median Days Payable is 59.73. Tatva Chintan Pharma Chem's value of 70.59 is 18.2% above this industry median. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #716 out of 1554 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #716 out of 1554 companies for Days Payable. This puts Tatva Chintan Pharma Chem in the upper half of its industry. The industry median Days Payable is 59.73. Tatva Chintan Pharma Chem's value of 70.59 is 18.2% above this benchmark. Historically, Tatva Chintan Pharma Chem's own Days Payable has ranged from 59.67 to 91.15 over the past decade. While the company's 10-year median is 72.61 vs. the industry median of 59.73, Tatva Chintan Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.73, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current Days Payable of 70.59 is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tatva Chintan Pharma Chem and its competitors. For the Chemicals industry, the median Days Payable is 59.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current Days Payable is 70.59, which is near median its own 10-year median of 72.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,496.57, compared to a current price of ₹1,722.40 — trading 15.1% above its estimated fair value. The current Days Payable is 70.59, which is near median its 10-year median of 72.61 and 18.2% above the Chemicals industry median of 59.73. Tatva Chintan Pharma Chem's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Days Payable is 70.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued.
The current stock price of ₹1,722.40 is trading 15.1% above its estimated GF Value™ of ₹1,496.57.
GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.
Key valuation signals for NSE:TATVA:
Days Payable: 70.59 (near median its 10-year median of 72.61)
GF Value™: ₹1,496.57 vs. price of ₹1,722.40 (15.1% above fair value)
Industry Position: 18.2% above the Chemicals median (#716 of 1554)
No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score
Get the complete analysis for NSE:TATVA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TATVA has been successfully added to your 
